-
Director, Advanced Practice Provider (APP) Initiatives
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...6 days ago on The Resumator -
Director, Global Health Economic and Outcomes Research (GHEOR)
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Sr. Director Pharmacovigilance Compliance
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...1 week ago on The Resumator -
Senior Director, Commercial Data Strategy & Management
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...2 weeks ago on The Resumator -
Director, Global Strategy and Forecasting
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...3 weeks ago on The Resumator -
Senior Director, Regulatory Affairs, Advertising and Promotion
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator -
Director, Regulatory Strategy
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator -
Director, Regulatory Labeling
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator -
IT Senior Director, Corporate Functions
Management & Exec · Madrigal Pharmaceuticals · Conshohocken, PAAbout Madrigal: Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was gr...Over 4 weeks ago on The Resumator